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Takayasu arteriopathy — rare,
but worth to remember disease
Choroba Takayasu — rzadka, ale godna zapamiętania
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Takayasu’s arteritis (TA) is very rare in general and also
Polish patient population (2.6 patients per million popula-
tion per year in US) [1] therefore this case report is an impor-
tant opportunity to discuss both the disease and its therapeu-
tic options. Its nature is autoimmune although some genetic
predisposition was also reported (HLA haplotype B52 and
DR4 are more common in this patient population). More-
over some infectious factors may coincide with the onset of
the disease. Heat shock protein HSP-65 found in aortic tis-
sue taken from the patients suffering from TA is similar to
Mycobacterium tuberculosis 65-kDa HSP [2]. This HSP can
be a target for the gamma-delta T-cells secreting in massive
amounts a membrane-disrupting protein — perforin. The
same authors [2] suggest that not only cellular but also hu-
moral immunologic response is activated in this disease. The
arterial wall that is involved in inflammatory process is affec-
ted through vasa vasorum and all layers of its structure are
being destroyed.
Clinically disease starts with symptoms consistent with
typical virus infection including fever, weight loss, myalgia and
arthralgia. In this phase it causes inflammatory infiltrates in all
three layers of the arteries. In the chronic phase intimal proli-
feration and fibrotic changes in the vessel wall lead to steno-
sis or aneurysm formation [3]. It is easier to establish the dia-
gnose in the first phase if the patient presents with the pain at
palpation of the affected artery (most often one of the caro-
tids). Later ischaemic symptoms and age of the patient (by
the rule below 40 — the main criterion in Ishikawa clinical
diagnosis but not so strongly supported in newer classifica-
tions) are the main clinical data for beginning right diagnostic
evaluation.
The disease can be devastating in the group of young
patients that consists predominantly of women (2–8 times
more frequently suffering from TA) [1] and in the group of
children the mortality can be as high as 35% at 5 years [4].
In the case report presented by Kalawski et al. [5] 37 ye-
ars old female patient presented typical vascular changes
observed in TA involving aortic arch branches, right coronary
artery (proximal narrowing) and aortic valve insufficiency. This
distribution of malformations is typical for Asian patients who
present vascular changes localised mainly in aortic arch, its
branches and ascending aorta [6], but in other groups renal
arteries and abdominal aorta can be also the main localisa-
tion of the disease [7] even in 38% of patients. The operation
was prompted by TIA that was the main cause for patient
admission and evaluation that has lead to semielective surge-
ry that was mainly aimed at solving the problem of RCA pro-
ximal occlusion and severe aortic valve insufficiency (patient
was referred to cardiac surgery department but not to vascu-
lar surgery department). Coronary arteries are reported to be
affected by inflammatory narrowing or occlusive changes in
10 to 30% of TA patients [8] and optimal results are achieved
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using surgical treatment predominantly with saphenous vein
grafts (36% of restenoses after surgical treatment vs 78% of
restenoses after angioplasties). This finding seems to be rela-
ted to report from American group [9] that stated that more
than two thirds of patients present difficulties in performing
routine daily activities and about one-fourth of all patients
are unable to work. Very good decision was made to reva-
scularise the supraaortic vessels at the same time because the
danger of the brain perfusion disturbances during operation
and periooperatively could have been high with a poor blo-
od supply diagnosed preoperatively. Unfortunately the case
report does not bring the clear information whether the per-
fusion of the brain was maintained through the graft during
cardiopulmonary bypass time. If the brain and upper extre-
mities revascularisation would not be possible during the same
operation the aortic valve replacement could have been re-
considered having in mind that heart failure can progress slow-
ly in the group of patients with TA and severe aortic insuffi-
ciency when inflammatory parameters and systemic hyper-
tension are under control [10]. Two more issues are worth
mentioning here. First: regarding not easy problem of the
perioperative antinflammatory treatment of the patients and
second: the durability of the anastomosis performed in aortic
tissue that can be affected by inflammatory changes at the
time of symptom-prompted operation or later on. Matsuura
et al. [11] presenting the results of 21 consecutive arch and
hemiarch operations in patients with TA supports the idea to
hamper the inflammatory process with preoperative steroid
administration lasting 8.1 years (mean). The aim of the treat-
ment in his strategy is bringing the ESR and CRP level to nor-
mal limits before the operation. From other hand Miyata et
al. [12] in his publication reporting the results of surgical inter-
ventions in 103 TA patients (treated over 40 years) does not
find any correlation between formation of the aneurysm in
the anastomosis and anti-inflammatory treatment regime. In
his analysis higher frequency of anastomotic aneurysm for-
mation was observed in patients in whom the anastomosis
was performed in the aneurysmatic but not stenotic tissue.
The overall anastomotic aneurysm formation in TA patients
was 12% at 20 years.
In the end we would like to congratulate dr Kalawski and
his coworkers for the successful treatment of the very com-
plex case.
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